Nootropil (Piracetam)

Piracetam modulates neuronal membrane fluidity and influences ion channels, enhancing the activity of AMPA and NMDA receptors. This improves neuroplasticity, cerebral blood flow, and oxygen utilization, thereby facilitating neurotransmission and supporting cognitive processes.

The dosage of Nootropil is determined by the prescribing clinician based on the individual patient's condition, age, renal and hepatic function, and response to therapy. Patients should follow the prescriber's instructions and not adjust the dose on their own.

The safety of piracetam in pregnancy and lactation has not been established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To order Nootropil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nootropil belongs to the racetam class, which differs from stimulants like modafinil or cholinesterase inhibitors used in Alzheimer’s disease. Racetams primarily modulate membrane fluidity and receptor activity, offering a distinct mechanism with a generally favorable safety profile compared with some alternatives.

Store Nootropil tablets at ambient temperature, below 25 °C, in the original container, protected from moisture and direct sunlight. Keep out of reach of children and do not use after the expiry date printed on the packaging.

Nootropil is taken orally as a tablet. Swallow the tablet whole with a glass of water, preferably with or after a meal, unless otherwise directed by the prescribing clinician.

Serious but rare risks include allergic skin reactions, hematologic abnormalities such as thrombocytopenia, seizure aggravation in susceptible individuals, significant mood changes, and hepatic dysfunction. Patients should seek medical attention if they experience any severe or unexpected symptoms.

Nootropil should be avoided in individuals with known hypersensitivity to piracetam or any excipients, in patients with severe renal or hepatic impairment unless closely monitored, and in pregnant or breastfeeding women unless the benefits outweigh the risks. Clinicians should assess each case individually.